Global Pediatrics Partnering Deal Trends, Players and Financials 2014-2019 – ResearchAndMarkets.com

Pediatrics Partnering 2014-2019: Deal Trends, Players and Financials”

report has been added to ResearchAndMarkets.com’s

Global Pediatrics Partnering 2014 to 2019 provides the full collection
of Pediatrics disease deals signed between the world’s pharmaceutical
and biotechnology companies since 2014.

Most of the deals included within the report occur when a licensee
obtains a right or an option right to license a licensor’s product or
technology. More often these days these deals tend to be multi-component
including both a collaborative R&D and a commercialization of outcomes

The report takes readers through the comprehensive Pediatrics disease
deal trends, key players and top deal values allowing the understanding
of how, why and under what terms companies are currently entering
Pediatrics deals.

The report presents financial deal terms values for Pediatrics deals,
where available listing by overall headline values, upfront payments,
milestones and royalties enabling readers to analyse and benchmark the
value of current deals.

The initial chapters of this report provide an orientation of Pediatrics
dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in Pediatrics dealmaking
since 2014 covering trends by year, deal type, stage of development,
technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline
value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading Pediatrics deals since 2014.
Deals are listed by headline value. The chapter includes the top 25 most
active Pediatrics dealmakers, together with a full listing of deals to
which they are a party. Where the deal has an agreement contract
published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to Pediatrics deals since 2014
where a deal contract is available, providing the user with direct
access to contracts as filed with the SEC regulatory authorities. Each
deal title links via Weblink to an online version of the deal record
contract document, providing easy access to each contract document on

Chapter 6 provides a comprehensive directory of all Pediatrics
partnering deals by specific Pediatrics target announced since 2014. The
chapter is organized by specific Pediatrics therapeutic target. Each
deal title links via Weblink to an online version of the deal record and
where available, the contract document, providing easy access to each
contract document on demand.

In addition, a comprehensive appendix is provided with each report of
all Pediatrics partnering deals signed and announced since 2014. The
appendices are organized by company A-Z, stage of development at
signing, deal type (collaborative R&D, co-promotion, licensing etc) and
technology type. Each deal title links via Weblink to an online version
of the deal record and where available, the contract document, providing
easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the
trends and activities in Pediatrics partnering and dealmaking since 2014.

In conclusion, this report provides everything a prospective dealmaker
needs to know about partnering in the research, development and
commercialization of Pediatrics technologies and products.

Report Scope

Global Pediatrics Partnering 2014 to 2019 includes:

  • Trends in Pediatrics dealmaking in the biopharma industry since 2014
  • Analysis of Pediatrics deal structure
  • Access to headline, upfront, milestone and royalty data
  • Access to hundreds of Pediatrics deal contract documents
  • Comprehensive access to over 3500 Pediatrics deal records
  • The leading Pediatrics deals by value since 2014
  • Most active Pediatrics dealmakers since 2014

In Global Pediatrics Partnering 2014 to 2019, available deals
and contracts are listed by:

  • Headline value
  • Upfront payment value
  • Royalty rate value
  • Stage of development at signing
  • Deal component type
  • Technology type
  • Specific therapy indication

Key Topics Covered:

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in Pediatrics dealmaking

2.1. Introduction

2.2. Pediatrics partnering over the years

2.3. Pediatrics partnering by deal type

2.4. Pediatrics partnering by industry sector

2.5. Pediatrics partnering by stage of development

2.6. Pediatrics partnering by technology type

2.7. Pediatrics partnering by therapeutic indication

Chapter 3 -Financial deal terms for Pediatrics partnering

3.1. Introduction

3.2. Disclosed financials terms for Pediatrics partnering

3.3. Pediatrics partnering headline values

3.4. Pediatrics deal upfront payments

3.5. Pediatrics deal milestone payments

3.6. Pediatrics royalty rates

Chapter 4 – Leading Pediatrics deals and dealmakers

4.1. Introduction

4.2. Most active in Pediatrics partnering

4.3. List of most active dealmakers in Pediatrics

4.4. Top Pediatrics deals by value

Chapter 5 – Pediatrics contract document directory

5.1. Introduction

5.2. Pediatrics partnering deals where contract document available

Chapter 6 – Pediatrics dealmaking by therapeutic target

6.1. Introduction

6.2. Deals by Pediatrics therapeutic target


Appendix 1 – Directory of Pediatrics deals by company A-Z 2014 to 2019

Appendix 2 – Directory of Pediatrics deals by deal type 2014 to 2019

Appendix 3 – Directory of Pediatrics deals by stage of development 2014
to 2019

Appendix 4 – Directory of Pediatrics deals by technology type 2014 to

For more information about this report visit https://www.researchandmarkets.com/research/vccnq2/global_pediatrics?w=4


Laura Wood, Senior Press Manager
[email protected]
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
For GMT Office Hours Call +353-1-416-8900
Topics: Pharmaceuticals,

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.